Notably, given overexpression of antiapoptotic BCL-2 family members is closely linked to therapeutic resistance in cancer cells, Obatoclax has been demonstrated to facilitate drug sensitization of chemoresistant cells in both hematological [23] and solid tumors [26]. The gene discussed is BCL2; the disease is cancer.